Studying prescription drug use and outcomes with medicaid claims data: Strengths, limitations, and strategies

Medical Care

Volumn 45, Issue 10 SUPPL. 2, 2007, Pages

  Crystal, Stephen ^a,b   Akincigil, Ayse ^a,b   Bilder, Scott ^a   Walkup, James T ^a,b  

^a The State University of New Jersey   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Adherence; Claims; Medicaid; Methodology; Outcomes; Prescription drugs

Indexed keywords

CONFERENCE PAPER; DIAGNOSIS RELATED GROUP; DRUG USE; HEALTH SERVICES RESEARCH; HUMAN; INFORMATION PROCESSING; INSURANCE; MANAGEMENT; MEDICAID; METHODOLOGY; PATIENT COMPLIANCE; REPRODUCIBILITY; STATISTICS; UNITED STATES;

DATA COLLECTION; DIAGNOSIS-RELATED GROUPS; DRUG UTILIZATION REVIEW; HEALTH SERVICES RESEARCH; HUMANS; INSURANCE CLAIM REVIEW; MEDICAID; PATIENT COMPLIANCE; POLICY MAKING; REPRODUCIBILITY OF RESULTS; UNITED STATES;

EID: 34848832401     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/mlr.0b013e31805371bf     Document Type: Review

References (46)

1. Davis MH, O'Brien E. Profile of persons with disabilities in Medicare and Medicaid. Health Care Financ Rev. 1996;17:179-211. (Pubitemid 126448879)
2. Long SK, King J, Coughlin TA. The health care experiences of rural Medicaid beneficiaries. J Health Care Poor Underserved. 2006;17:575-591. (Pubitemid 44432414)
3. Rupp K, Davies PS, Newcomb C, et al. A profile of children with disabilities receiving SSI: highlights from the National Survey of SSI Children and Families. Soc Secur Bull. 2005;66:21-48. (Pubitemid 43840600)
4. Centers for Medicaid and Medicare Services. 1996 Data Compendium, December 2006. Available at: http://www.cms.hhs.gov/DataCompendium/18-2006-Data- Compendium. Accessed February 16, 2007.
5. Centers for Medicare and Medicaid Services. MSIS Tables FY 2003. 1/1/2006. Available at: http://www.cms.hhs.gov/MedicaidDataSourcesGenInfo/02- MSISData.asp. Accessed September 11, 2006.
6. U.S. Census Bureau. Annual Estimates of the Population by Sex, Race and Hispanic or Latino Origin for the United States: April 1, 2000 to July 1, 2005 (NC-EST2005-03). Available at: http://www.census.gov/popest/national/asrh/NC- EST2005-srh.html. Accessed September 4, 2006.
7. Crystal S, Sambamoorthi U, Moynihan PJ, et al. Initiation and continuation of newer antiretroviral treatments among Medicaid recipients with AIDS. J Gen Intern Med. 2001;16:850-859. (Pubitemid 34015701)
8. Kendler KS, Gallagher TJ, Abelson JM, et al. Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey. Arch Gen Psychiatry. 1996;53:1022-1031. (Pubitemid 26384671)
9. Crystal S, Lo Sasso AT, Sambamoorthi U. Incidence and duration of hospitalizations among persons with AIDS: an event history approach. Health Serv Res. 1999;33:1611-1638. (Pubitemid 29081166)
10. Walkup J, Sambamoorthi U, Crystal S. Characteristics of persons with mental retardation and HIV/AIDS infection in a statewide Medicaid population. Am J Ment Retard. 1999;104:356-363.
11. Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med. 2006;354:2443-2451. (Pubitemid 43855047)
12. Olfson M, Marcus SC, Shaffer D. Antidepressant drug therapy and suicide in severely depressed children and adults: a case-control study. Arch Gen Psychiatry. 2006;63:865-872. (Pubitemid 44188479)
13. Motheral B, Brooks J, Clark MA, et al. A checklist for retroactive database studies-report of the ISPOR task force on retrospective databases. Value Health. 2003;6:90-97. (Pubitemid 36403125)
14. Holt K, Franks P, Meldrum S, et al. Mammography self-report and mammography claims: racial, ethnic, and socioeconomic discrepancies among elderly women. Med Care. 2006;44:513-518. (Pubitemid 44284290)
15. Hennessy S, Bilker WB, Weber A, et al. Descriptive analyses of the integrity of a US Medicaid claims database. Pharmacoepidemiol Drug Saf. 2003;12:103-111. (Pubitemid 36304760)
16. Crystal S, Sambamoorthi U, Walkup JT, et al. Diagnosis and treatment of depression in the elderly Medicare population: predictors, disparities, and trends. J Am Geriatr Soc. 2003;51:1718-1728. (Pubitemid 37543357)
17. Rawson NS, Malcolm E. Validity of the recording of ischemic heart disease and chronic obstructive pulmonary disease in the Saskatchewan health care datafiles. Stat Med. 1995;14:2627-2643. (Pubitemid 26014254)
18. Edouard L, Rawson NS. Reliability of the recording of hysterectomy in the Saskatchewan health care system. Br J Obstet Gynaecol. 1996;103: 891-897. (Pubitemid 26297914)
19. Walkup JT, Wei W, Sambamoorthi U, et al. Sensitivity of an AIDS case-finding algorithm: who are we missing? Med Care. 2004;42:756-763.
20. Keyes M, Andrews R, Mason ML. A methodology for building an AIDS research file using Medicaid claims and administrative data bases. J Acquir Immune Defic Syndr. 1991;4:1015-1024.
21. Fanning TR, Cosler LE. The quality of Medicaid data for HIV/AIDS research: examination of a statewide data base. AIDS Public Policy J. 1995;10:39-47.
22. Thornton C, Turner BJ. Methods for Identifying AIDS Cases in Medicare and Medicaid Claims Data. MPR Reference Number 8230-400. Princeton, NJ: Mathematica Policy Research; 1997.
23. Walkup JT, Boyer CA, Kellermann SL. Reliability of Medicaid claims files for use in psychiatric diagnoses and service delivery. Adm Policy Ment Health. 2000;27:129-139. (Pubitemid 30205260)
24. Rawson NS, Malcolm E, D'Arcy C. Reliability of the recording of schizophrenia and depressive disorder in the Saskatchewan health care datafiles. Soc Psychiatry Psychiatr Epidemiol. 1997;32:191-199. (Pubitemid 27258651)
25. Lurie N, Popkin M, Dysken M, et al. Accuracy of diagnoses of schizophrenia in Medicaid claims. Hosp Community Psychiatry. 1992; 43:69-71.
26. Grymonpre R, Cheang M, Fraser M, et al. Validity of a prescription claims database to estimate medication adherence in older persons. Med Care. 2006;44:471-477. (Pubitemid 43755427)
27. Nachega JB, Hislop M, Dowdy DW, et al. Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J Acquir Immune Defic Syndr. 2006;43:78-84. (Pubitemid 44306492)
28. Gable CB, Friedman RB, Holzer S, et al. Pharmacoepidemiological studies in automated claims databases: methodological issues. J Res Pharm Econ. 1992;4:53-67.
29. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50:105-116. (Pubitemid 27089212)
30. Hess LM, Raebel MA, Conner DA, et al. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40:1280-1288. (Pubitemid 44204957)
31. Walkup JT, Sambamoorthi U, Crystal S. Use of newer antiretroviral treatments among HIV-infected Medicaid beneficiaries with serious mental illness. J Clin Psychiatry. 2004;65:1180-1189.
32. Bagchi A, Sambamoorthi U, McSpiritt E, et al. Use of antipsychotic medications among HIV-infected individuals with schizophrenia. Schizophr Res. 2004;71:435-444. (Pubitemid 39330522)
33. National Committee for Quality Assurance. HEDIS 2004. Vol 2: Technical Specifications. Washington, DC: NCQA Press; 2003.
34. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383. (Pubitemid 17055592)
35. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
36. Martens EP, Pestman WR, de Boer A, et al. Instrumental variables: application and limitations. Epidemiology. 2006;17:260-267.
37. Brookhart MA, Wang PS, Solomon DH, et al. Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Epidemiology. 2006;17:268-275.
38. Soumerai SB, McLaughlin TJ, Ross-Degnan D, et al. Effects of a limit on Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med. 1994;331:650-655. (Pubitemid 24276866)
39. Akincigil A, Bowblis J, Levin C, et al. Refill persistence with beta-blocker, ACE inhibitor, and statin therapy after an acute myocardial infarction. Presented at the Sixth Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, 2005; Washington, DC.
40. Himelhoch S, Moore RD, Treisman G, et al. Does the presence of a current psychiatric disorder in AIDS patients affect the initiation of antiretroviral treatment and duration of therapy? J Acquir Immune Defic Syndr. 2004;37:1457-1463. (Pubitemid 39602335)
41. Melfi C, Croghan TW, Hanna MP, et al. Racial variation in antidepressant treatment in a Medicaid population. J Clin Psychiatry. 2000;61:16-21. (Pubitemid 30104378)
42. Litaker D, Koroukian S, Frolkis JP, et al. Disparities among the disadvantaged: variation in lipid management in the Ohio Medicaid program. Prev Med. 2006;42:313-315.
43. Agency for Healthcare Research and Quality. 2005 National Healthcare Disparities Report. Rockville, MD: Agency for Healthcare Research and Quality; 2005. AHRQ Publication No. 06-0017.
44. Food and Drug Administration. 2006 Safety Alerts for Drugs, Biologics, Medical Devices, and Dietary Supplements. Available at: http://www.fda.gov/ medwatch/safety/2006/safety06.htm#chronological. Accessed February 15, 2007.
45. Day S. Issues in Medicaid policy and system transformation: recommendations from the President's Commission. Psychiatric Serv. 2006; 57:1713-1718. (Pubitemid 46051324)
46. Iglehart JK. Medicaid revisited-skirmishes over a vast public enterprise. N Engl J Med. 2007;357:734-740.